Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity

scientific article published on 28 October 2015

Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1078-0432.CCR-15-1080
P8608Fatcat IDrelease_jiwtudjqa5ddtmite4snhkvvre
P932PMC publication ID4751620
P698PubMed publication ID26510858

P50authorAlison DunningQ30506457
Kyriaki MichailidouQ37070465
Catharine M. WestQ41672038
Paul D P PharoahQ61822938
Neil G BurnetQ63783501
P2093author name stringCharlotte E Coles
John Yarnold
Gillian C Barnett
Leila Dorling
Rebecca M Elliott
P2860cites workAn integrated map of genetic variation from 1,092 human genomesQ22122153
Genotype imputation with thousands of genomesQ24633967
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studiesQ33909674
Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.Q34169664
A linear complexity phasing method for thousands of genomesQ34237936
Secretome analysis of ionizing radiation-induced senescent cancer cells reveals that secreted RKIP plays a critical role in neighboring cell migrationQ34352155
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumQ34379032
Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?Q34390257
Chromosomal radiosensitivity and low penetrance predisposition to cancerQ35783291
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerQ35996692
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialQ36571627
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Chromosomal radiosensitivity as a marker of predisposition to common cancers?Q36622846
STROGAR - STrengthening the Reporting Of Genetic Association studies in RadiogenomicsQ36672778
Variants in the ATM gene and breast cancer susceptibilityQ37118296
A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicityQ39200585
Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseasesQ45210812
Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individualsQ46703167
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysisQ46707380
Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer.Q50734229
Radiosensitivity, Radiogenomics and RAPPERQ57306190
Patient-to-patient variability in the expression of radiation-induced normal tissue injuryQ57618664
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)1413-1420
P577publication date2015-10-28
P1433published inClinical Cancer ResearchQ332253
P1476titlePatients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity
P478volume22

Reverse relations

cites work (P2860)
Q38613552Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
Q30234489Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.
Q36690194Epigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis
Q41899048Improving radiotherapy in cancer treatment: Promises and challenges
Q89060421Radiation biology and oncology in the genomic era

Search more.